An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Clinical trial NCT03467958 · TERMINATED
Trial details
- NCT number
- NCT03467958
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-24
- Primary completion
- 2024-10-31
- Enrollment
- 854
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.